JAK2 and diffuse large B-cell lymphoma: ctDNA analysis utilising an extended gene panel at Hodgkin relapse demonstrated persisting, high‐VAF TP53 variants with new mutations in SF3B1, JAK2 and FAT1 but not the IGLL5 mutations previously associated with DLBCL.